Browsing Over 10 ePosters
Category- Translational research
Filtered By
- Translational research
Sort By
Translational research
No ePoster preview available
51PD - Effect of MEK inhibition on PDL1 and and on cytokinesproduction profilein NSCLC cell lines and in human lymphocites
Authors
- Floriana Morgillo (IT)
- Carminia Maria Della Corte (IT)
- Giuseppe Viscardi (IT)
- Raimondo Di Liello (IT)
- Federica Papaccio (IT)
- Fortunato Ciardiello (IT)
Presenter
- Floriana Morgillo (IT)
Translational research
53P - Lung cancer: Beyond EGFR and ALK dichotomy
Authors
- Chiradoni T. Satheesh (IN)
- Amit D. Bhatt (IN)
- Manish Singhal (IN)
- R Aarthi (IN)
- K Shubham (IN)
- G Madhura (IN)
- Vinayak Maka (IN)
- Radheshyam Naik (IN)
- Sandhya Iyer (IN)
- GOWHAR SHAFI (IN)
Presenter
- Chiradoni T. Satheesh (IN)
Translational research
54P - Epidermal growth factor receptor expression (EGFR) in serum as a marker of treatment response and survival in advanced squamous cell lung cancer
Authors
- Anant Mohan (IN)
- Ashraf Ansari (IN)
- Mirza Masroor (IN)
- Alpana Saxena (IN)
- Kalpana Luthra (IN)
- Ravindra M. Pandey (IN)
- Deepali Jain (IN)
- Rakesh Kumar (IN)
- G C Khilnani (IN)
- Randeep Guleria (IN)
Presenter
- Anant Mohan (IN)
Translational research
57P - Targeted sequencing of plasma-derived cfDNA in patients with metastatic NSCLC
Authors
- Raffaella Pasquale (IT)
- Francesca Bergantino (IT)
- Francesca Fenizia (IT)
- Laura Forgione (IT)
- Cristin Roma (IT)
- Antonella De Luca (IT)
- Gaetano Rocco (IT)
- Alessandro Morabito (IT)
- Nicola Normanno (IT)
Presenter
- Raffaella Pasquale (IT)
Translational research
58P - Co-treatment of trametinib (MEK inhibitor) with TPX-0005 (Src/FAK/JAK2 inhibitor) synergistic in KRAS mutant NSCLC cell lines and CDCP1 acts as a biomarker in KRAS mutant patients (p)
Authors
- Carles Codony-Servat (ES)
- MARIA Llanos Gil Moreno (ES)
- Jillian Bracht (ES)
- Ilaria Attili (IT)
- Chiara Lazzari (IT)
- Vanesa Gregorc (IT)
- Masaoki Ito (JP)
- Santiago Viteri (ES)
- Niki Karachaliou (ES)
- Rafael Rosell (ES)
Presenter
- Carles Codony-Servat (ES)
Translational research
59P - Circulating microRNAs as novel predictive markers of afatinib efficacy in squamous cell lung cancer (SCC): An exploratory sub-analysis of the LUX-Lung 8 trial
Authors
- Yann Gaston Math_ (FR)
- Paul Fogel (FR)
- Séverine Martin-Lannerée (FR)
- Charles Marcaillou (FR)
- Elodie Lallet (FR)
- Nicole Krämer (DE)
- Neil Gibson (NA)
- Flavio Solca (AT)
- Eva Ehrnrooth (DK)
- Jacques Cadranel (FR)
Presenter
- Yann Gaston Math_ (FR)
Translational research
60P - Circulating miR-31 as a predictive marker of EGFR TKI treatment efficacy in squamous cell lung cancer (SCC): A sub-analysis of the LUX-Lung 8 trial
Authors
- Yann Gaston Math_ (FR)
- Paul Fogel (FR)
- Séverine Martin-Lannerée (FR)
- Charles Marcaillou (FR)
- Elodie Lallet (FR)
- Nicole Krämer (DE)
- Neil Gibson (NA)
- Flavio Solca (AT)
- Eva Ehrnrooth (DK)
- Jacques Cadranel (FR)
Presenter
- Yann Gaston Math_ (FR)
Translational research
64P - Cisplatin-resistant phenotype: Characterization, adaptation to EGFR signaling and sensitivity to EGFR inhibitors in NSCLC cells
Authors
- Venu Pamidiboina (DE)
- Fei Tian (DE)
- Rosemarie Kiefl (DE)
- Marina Schaule (DE)
- Rudolf Maria Huber (DE)
Presenter
- Venu Pamidiboina (DE)
Translational research
65P - Fatty acid synthase (FASN) inhibition effect on EGFR TKIs sensitive and resistant cells
Authors
- Santiago Ruíz Martínez (ES)
- Joaquim Bosch-Barrera (ES)
- Marta Planas (ES)
- Lidia Feliu (ES)
- Rut Porta-Balanya (ES)
- Teresa Puig (ES)
Presenter
- Santiago Ruíz Martínez (ES)
Translational research
66P - PALB2 mRNA expression as a predictive marker in advanced non-small cell lung cancer (NSCLC) patients (p) treated with docetaxel-cisplatin
Authors
- Niki Karachaliou (ES)
- Jordi Berenguer (ES)
- Imane Chaib (ES)
- José Luis Ramírez Serrano (ES)
- Maria Teresa Moran Bueno (ES)
- Bartomeu Massuti Sureda (ES)
- Silvia Calabuig Fariñas (ES)
- Carlos Camps (ES)
- Mariano Provencio Pulla (ES)
- Rafael Rosell (ES)
Presenter
- Niki Karachaliou (ES)